• Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

  • 2025/02/06
  • 再生時間: 5 分
  • ポッドキャスト

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

  • サマリー

  • In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.

    続きを読む 一部表示

あらすじ・解説

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.

activate_buybox_copy_target_t1

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessmentに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。